To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Adaptilens fetches $1.6m seed
Boston-based Adaptilens, a developer of an adjustable intraocular lens, has secured $1.6 million in seed funding.
